About the Journal

European Journal of Pharmaceutical Research (EJ-PHARMA) is a peer-reviewed international journal published by European Open Science bimonthly. The journal publishes full-length state-of-the-art research papers, reviews, and case studies in all areas related to all areas to related Pharmaceutical Research.

All submitted articles:

  • - must be original
  • - must be previously unpublished research results
  • - must be experimental or theoretical
  • - and will be peer-reviewed
  • - may not be considered for publication elsewhere at any time during the review period

 

Author Fees

European Journal of Pharmaceutical Research (EJ-PHARMA) follows a publication model that allows us to minimize publishing costs. This model aims to delegate manuscript copyediting/layout-adaptation efforts to authors so that they do not have to pay for these services.

The journal charges the following author fees:

  • - Article Publication Fee: 55.00 GBP (compulsory) 
  • - Template Support Fee: 50.00 GBP (optional)

If a manuscript is accepted for publication, the authors will be asked to pay an Article Publication Fee (APF) to cover publication costs.

NOTE : All accepted manuscripts are obligated to adapt the layout of the paper according to the journal's template. If you are unable to adapt your submission manuscript to our template, EJ-PHARMA support crew may provide this service for the authors by charging a Template Support Fee of 50.00 GBP.

DISCOUNT SCHEMA :

  • - Authors are subject to a 20% discount for their recurring publication within 5 months after the date of their first publication.
  • - For more information please check out the discount page.

 

Indexing

The content of the journal is indexed in CrossRef and assigned a Digital Object Identifier (DOI). This means that all of our references are made available and citations can be tracked by the publishing community with a DOI number.

In addition, this journal is indexed in Google Scholar, ROAD, SCILIT, WorldCat, ScienceOpen.

 

Zero Tolerance for Plagiarism

This journal has a policy of “Zero Tolerance on Plagiarism”. We check the plagiarism issue through two methods: reviewer check and plagiarism prevention tool (iThenticate.com). All submissions will be checked by plagiarism prevention software before being sent to reviewers.

 

Focus and Scope

European Journal of Pharmaceutical Research (EJ-PHARMA) is a high quality, open access, international, peer-reviewed online journal which aims to bi-monthly publish full-length original research papers, reviews, case studies related to all areas of Pharmaceutical Research such as :

  • Biopharmaceutics
  • Biotechnology/pharmaceutical technology
  • Chemical processing of pharmaceuticals,
  • Chemical stability of drugs
  • Crystallization
  • Dosage form design
  • lyophilization
  • Metabolic disposition of bioactive agents
  • Pharmacodynamics
  • Pharmacokinetics
  • Physical chemistry
  • Pro-drug developments
  • Protein-peptide chemistry 
  • Targeted drug delivery

 

Peer-Reviewing Process

 The process of reviewing is considered critical to establishing a reliable body of research and knowledge. The review process aims to make authors meet the standards of their discipline, and of science in general.

We use a double-blind system for peer-reviewing; both reviewers and authors’ identities remain anonymous to each other. The paper will be peer-reviewed by two or three experts; one is an editorial staff and the other two are external reviewers. 

The editor will pass the manuscripts that are accepted for publication to a publisher who will be responsible for organizing the editorial services and online printing of the publication.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available after publication on the EJ-PHARMA website to the public supports a greater global exchange of knowledge.

 

Publication Ethics and Publication Malpractice Statement

The publication of an article in the peer-reviewed European Journal of Pharmaceutical Research (EJ-PHARMA) is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the authors, the journal editors, the peer reviewers, the publisher, and the society.
 
The ethics statements for our journal are based on the Committee on Publication Ethics (COPE) Best Practice Guidelines for Journal Editors.
 

Manuscript Withdrawal and Refund Policies

Authors can withdraw their manuscript at any stage of submission, peer-reviewing, and copyediting procedures. However, withdrawals after the copyediting process are not subject to the refund of the Article Processing Fee.